Psychedelic Medicine Is Having an Identity Crisis — And That’s a Good Thing

For most of the last decade, the story of psychedelic medicine was a story about the trip itself. Guided sessions. Eyeshades and headphones. A therapist sitting with a patient for six or eight hours while a single dose of psilocybin or MDMA did its work. That was the model — expensive, logistically heavy, and philosophically tied to the idea that the altered state of consciousness was the medicine. The post Psychedelic Medicine Is Having an Identity Crisis — And That’s a Good Thing appeared first on Microdose.